Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-07

FDA Approved: BENZNIDAZOLE — Supplemental Application (Exeltis USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for benznidazole from Exeltis USA, Inc., updating the labeling for this product. This reflects a change to the appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benznidazole (benznidazole)

Snippet

SUPPL AP for BENZNIDAZOLE (BENZNIDAZOLE)